Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0017636 (
glioblastoma
)
18,345
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Glioblastoma
(
GBM
) is both the most common and the most lethal primary brain tumor. It is thought that
GBM
stem cells (GSCs) are critically important in resistance to therapy. Therefore, there is a strong rationale to target these cells in order to develop new molecular therapies.To identify molecular targets in GSCs, we compared gene expression in GSCs to that in neural stem cells (NSCs) from the adult human brain, using microarrays. Bioinformatic filtering identified 20 genes (PBK/TOPK, CENPA, KIF15, DEPDC1, CDC6, DLG7/DLGAP5/HURP, KIF18A, EZH2,
HMMR
/RHAMM/CD168, NOL4, MPP6, MDM1, RAPGEF4, RHBDD1, FNDC3B, FILIP1L, MCC, ATXN7L4/ATXN7L1, P2RY5/LPAR6 and FAM118A) that were consistently expressed in GSC cultures and consistently not expressed in NSC cultures. The expression of these genes was confirmed in clinical samples (TCGA and REMBRANDT). The first nine genes were highly co-expressed in all
GBM
subtypes and were part of the same protein-protein interaction network. Furthermore, their combined up-regulation correlated negatively with patient survival in the mesenchymal
GBM
subtype. Using targeted proteomics and the COGNOSCENTE database we linked these genes to
GBM
signalling pathways.Nine genes: PBK, CENPA, KIF15, DEPDC1, CDC6, DLG7, KIF18A, EZH2 and
HMMR
should be further explored as targets for treatment of
GBM
.
...
PMID:Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells. 2629 6
Emergent evidences revealed that long noncoding RNAs (lncRNAs) participate in neoplastic progression.
HMMR
is an oncogene that is highly expressed in
glioblastoma
(
GBM
) and supports
GBM
growth. Whether lncRNAs regulate
HMMR
in
GBM
remains unknown. Herein, we identify that an
HMMR
antisense lncRNA,
HMMR
-AS1, is hyperexpressed in
GBM
cell lines and stabilizes
HMMR
mRNA. Knockdown of
HMMR
-AS1 reduces
HMMR
expression; inhibits cell migration, invasion, and mesenchymal phenotypes; and suppresses
GBM
cell growth both in vitro and in vivo. Moreover, knockdown of
HMMR
-AS1 radiosensitizes
GBM
by reducing DNA repair proteins ATM, RAD51, and BMI1. Our data demonstrate a mechanism of sense-antisense interference between
HMMR
and
HMMR
-AS1 in
GBM
and suggest that targeting
HMMR
-AS1 is a potential strategy for
GBM
treatment.
...
PMID:Targeting Long Noncoding RNA HMMR-AS1 Suppresses and Radiosensitizes Glioblastoma. 2957 52